Target intelligence / Profile preview

Elongin C pseudogene 13 (ELOCP13)

Target: ELOCP13
Molecular classification: Other (pseudogene; not a functional protein, enzyme, receptor, transporter, or transcription factor)

Overview

Elongin C pseudogene 13 (ELOCP13) is a non-protein-coding gene annotated in the human genome, derived from duplication or retrotransposition of the functional elongin C gene (ELOC). Unlike its counterpart ELOC, ELOCP13 does not produce a functional protein and is classified as a pseudogene. It has no known biological activity, is not involved in disease or therapeutic mechanisms, has not been linked to drug interactions, and is not considered a valid molecular target for drug development or biomarker analysis.

Other names: TCEB1P13Transcription elongation factor B (SIII), polypeptide 1 pseudogene 13Transcription elongation factor B subunit 1 pseudogene 13ELOCP13

Mechanism of action

None (no drugs or agents act via ELOCP13)

Biological functions

None (no known functions; does not encode protein or regulate processes)

Disease associations

None (not associated with disease phenotypes, not implicated as a causal or modifier locus)

Safety considerations

None (no safety or pharmacological implications)

Interacting drugs

None (no drugs interact with ELOCP13, as it is not a protein)

Biomarkers

None (not used as a biomarker for patient selection or therapeutic monitoring)

Beyond the preview

Go deeper on Elongin C pseudogene 13 (ELOCP13).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Elongin C pseudogene 13 (ELOCP13).

Explore the full profile